---
permalink: /
title: ""
excerpt: ""
author_profile: true
redirect_from: 
  - /about/
  - /about.html
---

{% if site.google_scholar_stats_use_cdn %}
{% assign gsDataBaseUrl = "https://cdn.jsdelivr.net/gh/" | append: site.repository | append: "@" %}
{% else %}
{% assign gsDataBaseUrl = "https://raw.githubusercontent.com/" | append: site.repository | append: "/" %}
{% endif %}
{% assign url = gsDataBaseUrl | append: "google-scholar-stats/gs_data_shieldsio.json" %}

<span class='anchor' id='about-me'></span>

I'm currently a senior student in China Pharmaceutical Univeristy. I majoy in Medicinal Chemistry and I'll get my Bachelor's Degree in 2025. From my point of view, progressing in Pharmaceutical Science demands a commitment to research and staying at the cutting edge of drug discovery, development, and delivery. I Familiarize myself with recent advancements in genomics, computational biology, and bioinformatics, as they increasingly play a role in drug development.





# ğŸ“ Publications 

<div class='paper-box'><div class='paper-box-image'><div><div class="badge">2024</div><img src='images/pub-fig1.png' alt="sym" width="100%"></div></div>
<div class='paper-box-text' markdown="1">

[Discovery of FLT3-targeting PROTACs with potent antiproliferative activity against acute myeloid leukemia cells harboring FLT3 mutations](https://doi.org/10.1016/j.ejmech.2024.116237)

Zhijie Wang\*, Xun Lu\*, **Canlin Liu\***(co-first author), Fei Huang, Tao Lu, Yadong Chen, Lifei Liu, Shuai Lu

- A FLT3 PROTAC molecule 35 with novel structure was discovered.
- Comparative MD simulations elucidated the mechanism of 35 to stabilize the FLT3â€”35â€”CRBN ternary complex.
- The â€œzipperâ€ mechanism of 35 was first proposed in the field of PROTACs.
- 35 possessed selective antiproliferative activities against FLT3-mutated AML cells.

</div></div>

<div class='paper-box'><div class='paper-box-image'><div><div class="badge">2023</div><img src='images/pub2.png' alt="sym" width="100%"></div></div>
<div class='paper-box-text' markdown="1">

[Rational discovery of dual FLT3/HDAC inhibitors as a potential AML therapy](https://doi.org/10.1016/j.ejmech.2023.115759)

Zhijie Wang, Donglin Wu, Xiaofei Zhao, **Canlin Liu**, Siming Jia, Qindi He, Fei Huang, Zitian Cheng, Tao Lu, Yadong Chen, Yun Chen, Pei Yang, Shuai Lu

- New therapies are urgently needed for patients with AML.
- Dual FLT3/HDAC inhibitors were got by structure design strategy for the first time.
- 63 effectively inhibited the proliferation of MV4-11 cells.
- Antitumor activity was dependent on the dual inhibition of FLT3 and HDAC1.

</div></div>

<div class='paper-box'><div class='paper-box-image'><div><div class="badge">2023</div><img src='images/pub3.png' alt="sym" width="100%"></div></div>
<div class='paper-box-text' markdown="1">

[Hydrophobic tag-based protein degradation: Development, opportunity and challenge](https://www.sciencedirect.com/science/article/abs/pii/S0223523423007080?via%3Dihub)

Qindi He, Xiaofei Zhao, Donglin Wu, Siming Jia, **Canlin Liu**, Zitian Cheng, Fei Huang, Yadong Chen, Tao Lu, Shuai Lu

- Hydrophobic tagged proteins are efficiently degraded.
- Hydrophobic tag-mediated protein degradation occur through various pathways.
- Hydrophobic tag-based protein degradation has better drug likeness properties.
</div>
</div>

# ğŸ– Honors and Awards
<img src='images/forum2.png' width="280" height="140" align="left" /><img src='images/forum1.png' width="110" height="140" align="left" /> 

- *2023.10* The First Prize in the 15th National Student Pharmaceutical Forum  
- *2023.10* The Outstanding Paper Award in the 15th National Student pharmaceutical Forum  
- *2022.10* The Second Prize in the National English Speech Contest of Uchallenge
- *2022.09* Merit Students, China Pharmaceutical University
- *2022.09* Scholarships - Outstanding Students

# ğŸ“– Educations
- *2021.06 - 2024.11 (now)*, Department of Pharmarcy, China Pharmaceutical University 
 

# ğŸ’¬ Invited Talks
- *2021.06*, Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus ornare aliquet ipsum, ac tempus justo dapibus sit amet. 
- *2021.03*, Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus ornare aliquet ipsum, ac tempus justo dapibus sit amet.  \| [videovideo](https://github.com/)

# ğŸƒ Hobbies
<img src='images/mountain1.png' width="140" height="140" align="left" /><img src='images/mountain2.png' width="100" height="140" align="left" /> 

- Mountain Climbing
- Hiking
**"Climb mountains not so the world can see you, but so you can see the world." â€” David McCullough Jr.**



æ— åºåˆ—è¡¨
- asd

æ’å…¥ç…§ç‰‡
![1](images/android-chrome-512x512.png)

æ–œä½“
*123*

ç²—
**123**

å¤§æ ‡é¢˜
# 12
## 12
### 12


<div class='paper-box'><div class='paper-box-image'><div><div class="badge">2024</div><img src='images/500x300.png' alt="sym" width="100%"></div></div>
<div class='paper-box-text' markdown="1">

[Deep Residual Learning for Image Recognition](https://openaccess.thecvf.com/content_cvpr_2016/papers/He_Deep_Residual_Learning_CVPR_2016_paper.pdf)

**Kaiming He**, Xiangyu Zhang, Shaoqing Ren, Jian Sun

- Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus ornare aliquet ipsum, ac tempus justo dapibus sit amet. 
</div>
</div>

ä½ è¦æ”¹images/500x300.pngè¿™ä¸ªä¸œè¥¿ï¼Œè¿™ä¸ªæ˜¯è®ºæ–‡æ‘˜é€‰å›¾ç‰‡ï¼Œåˆ«äººä¸€çœ‹å°±çŸ¥é“ä½ åšäº†ä»€ä¹ˆçš„æœ€å¥½ï¼Œç„¶åæ”¾åœ¨imagesæ–‡ä»¶å¤¹ä¸‹é¢ï¼Œimages/500x300.pngå°±ä»£è¡¨è¿™ä¸ªå›¾ç‰‡çš„ä½ç½®500x300.pngå°±æ˜¯å›¾ç‰‡åå­—

https://openaccess.thecvf.com/content_cvpr_2016/papers/He_Deep_Residual_Learning_CVPR_2016_paper.pdfè¿™ä¸ªæ˜¯ä½ è®ºæ–‡çš„åœ°å€